Agilent Technologies Stock News

Agilent and UVM announce the Agilent Laboratory for Chemical Analysis (ALCA) Vermont Biz

Agilent Technologies Inc''s (NYSE: A ) short percent of float has risen 7.36% since its last report. The company recently reported that it has 5.24 million shares sold short , which is 1.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.1 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of … Full story available on Benzinga.com

Agilent (A) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earn

Agilent (A) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earn

Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, announced a partnership with Agilent Technologies demonstrating integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic tools. Latest Aithority Insights: Yanmar Invests $21 Million in GetMyBoat as Part of Series B Funding to […] The post Element Biosciences Partners with Agilent Technologies To Validate SureSelect Target Enrichment Panels on Element’s AVITI System appeared first on AiThority .

Over the past 3 months, 4 analysts have published their opinion on Agilent Technologies (NYSE:A) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a

Over the past 3 months, 4 analysts have published their opinion on Agilent Technologies (NYSE: A ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 1 0 0 Last 30D 1 2 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Agilent Technologies has an average price target of $156.25 with a high … Full story available on Benzinga.com

Agilent Technologies Inc (NYSE: A ) reported Q1 FY22 revenues rose 8% Y/Y to $1.67 billion , beating analysts average estimate of $1.46 billion. The firm said core revenues, which exclude the impact of currency and acquisitions and divestitures over the last 12 months, grew 9%. Agilent said that revenues for its diagnostics and genomic group rose 15% Full story available on Benzinga.com

Agilent's (A) fiscal first-quarter results benefit from solid momentum across all operating segments. Further, strong growth in the pharma market remains a tailwind.

Agilent's (A) fiscal first-quarter results benefit from solid momentum across all operating segments. Further, strong growth in the pharma market remains a tailwind.

A earnings call for the period ending December 31, 2021.

A earnings call for the period ending December 31, 2021.

Agilent Technologies, Inc. (NYSE: A) Q1 2022 earnings call dated Feb. 22, 2022 Corporate Participants: Parmeet Ahuja Vice President, Investor Relations Mike McMullen President and Chief Executive Officer Robert W. McMahon Senior Vice [] The post Agilent Technologies, Inc. (A) Q1 2022 Earnings Call Transcript first appeared on AlphaStreet .